# Pamela J. Shaw

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pamela-j-shaw/

## Facts

| Field | Value |
| --- | --- |
| Citations | 53,654 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 118 |
| i10-index | 494 |
| Last Known Institution | Sheffield Teaching Hospitals NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5087727224 |
| ORCID iD | https://orcid.org/0000-0002-8925-2567 |
| Works | 863 |

## Researcher papers

Showing 12 of 13.

- [Amyotrophic lateral sclerosis](https://scholariq.org/papers/amyotrophic-lateral-sclerosis-3/)
- [Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study](https://scholariq.org/papers/frequency-of-the-c9orf72-hexanucleotide-repeat-expansion-in-patients-with/)
- [Amyotrophic lateral sclerosis](https://scholariq.org/papers/amyotrophic-lateral-sclerosis-4/)
- [Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS](https://scholariq.org/papers/trial-of-antisense-oligonucleotide-tofersen-for-i-sod1-i-als/)
- [Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis](https://scholariq.org/papers/genome-wide-association-analyses-identify-new-risk-variants-and-the-genetic/)
- [Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology](https://scholariq.org/papers/common-and-rare-variant-association-analyses-in-amyotrophic-lateral-sclerosis/)
- [Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS](https://scholariq.org/papers/phase-1-2-trial-of-antisense-oligonucleotide-tofersen-for-i-sod1-i-als/)
- [Controversies and priorities in amyotrophic lateral sclerosis](https://scholariq.org/papers/controversies-and-priorities-in-amyotrophic-lateral-sclerosis/)
- [Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model](https://scholariq.org/papers/prognosis-for-patients-with-amyotrophic-lateral-sclerosis-development-and/)
- [Exome-wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS](https://scholariq.org/papers/exome-wide-rare-variant-analysis-identifies-tuba4a-mutations-associated-with/)
- [NEK1 variants confer susceptibility to amyotrophic lateral sclerosis](https://scholariq.org/papers/nek1-variants-confer-susceptibility-to-amyotrophic-lateral-sclerosis/)
- [The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder](https://scholariq.org/papers/the-c9orf72-expansion-mutation-is-a-common-cause-of-als-ftd-in-europe-and-has-a/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological diseases and metabolism](https://scholariq.org/topics/neurological-diseases-and-metabolism/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)

## Researcher university

- [Sheffield Teaching Hospitals NHS Foundation Trust](https://scholariq.org/institutions/sheffield-teaching-hospitals-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.